NO965050L - A- og B-polymorfene av 1-(difenylmetyl)-4- 3-(2-fenyl-1,3-dioksolan-2-yl)propyl -piperazin - Google Patents

A- og B-polymorfene av 1-(difenylmetyl)-4- 3-(2-fenyl-1,3-dioksolan-2-yl)propyl -piperazin

Info

Publication number
NO965050L
NO965050L NO965050A NO965050A NO965050L NO 965050 L NO965050 L NO 965050L NO 965050 A NO965050 A NO 965050A NO 965050 A NO965050 A NO 965050A NO 965050 L NO965050 L NO 965050L
Authority
NO
Norway
Prior art keywords
diphenylmethyl
dioxolan
phenyl
propylpiperazine
polymorphs
Prior art date
Application number
NO965050A
Other languages
English (en)
Norwegian (no)
Other versions
NO965050D0 (no
Inventor
Rafael Ambros Foguet
Lluis Burniol Anglada
Jose A Hernandez Ortiz
Aurelio Munos Sacristan
Josep Maria Barenys Castello
Manuel M Raga
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO965050D0 publication Critical patent/NO965050D0/no
Publication of NO965050L publication Critical patent/NO965050L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO965050A 1995-03-28 1996-11-27 A- og B-polymorfene av 1-(difenylmetyl)-4- 3-(2-fenyl-1,3-dioksolan-2-yl)propyl -piperazin NO965050L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES1995/000033 WO1996030366A1 (es) 1995-03-28 1995-03-28 Polimorfos a y b de 1-(difenilmetil)-4-[3-(2-fenil-1,3-dioxolan-2-il)propil]piperazina

Publications (2)

Publication Number Publication Date
NO965050D0 NO965050D0 (no) 1996-11-27
NO965050L true NO965050L (no) 1996-11-27

Family

ID=8289110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965050A NO965050L (no) 1995-03-28 1996-11-27 A- og B-polymorfene av 1-(difenylmetyl)-4- 3-(2-fenyl-1,3-dioksolan-2-yl)propyl -piperazin

Country Status (14)

Country Link
US (1) US5852021A (da)
EP (1) EP0785196B1 (da)
JP (1) JPH10501555A (da)
KR (1) KR970703337A (da)
AT (1) ATE194004T1 (da)
AU (1) AU690974B2 (da)
DE (1) DE69517593T2 (da)
DK (1) DK0785196T3 (da)
ES (1) ES2149353T3 (da)
FI (1) FI964653A7 (da)
GR (1) GR3034463T3 (da)
NO (1) NO965050L (da)
PT (1) PT785196E (da)
WO (1) WO1996030366A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES514340A0 (es) * 1982-06-17 1983-09-01 Ferrer Int "procedimiento de obtencion de nuevos derivados de piperazina".

Also Published As

Publication number Publication date
AU690974B2 (en) 1998-05-07
US5852021A (en) 1998-12-22
AU2074095A (en) 1996-10-16
GR3034463T3 (en) 2000-12-29
FI964653L (fi) 1996-11-21
WO1996030366A1 (es) 1996-10-03
FI964653A0 (fi) 1996-11-21
JPH10501555A (ja) 1998-02-10
NO965050D0 (no) 1996-11-27
FI964653A7 (fi) 1996-11-21
EP0785196B1 (en) 2000-06-21
DE69517593D1 (de) 2000-07-27
DE69517593T2 (de) 2001-03-08
ES2149353T3 (es) 2000-11-01
EP0785196A1 (en) 1997-07-23
KR970703337A (ko) 1997-07-03
PT785196E (pt) 2000-12-29
ATE194004T1 (de) 2000-07-15
DK0785196T3 (da) 2000-10-16

Similar Documents

Publication Publication Date Title
NO986055L (no) Nye heterocykliske forbindelser, deres fremstilling, farmas°ytiske preparater inneholdende forbindelsene og deres anvendelse ved behandling av diabetes og beslektede sykdommer
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
EP0866059A4 (en) NOVEL HETEROCYCLIC DERIVATIVES AND THEIR MEDICINAL USE
CA2258949A1 (en) Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
MY109265A (en) A salt of 3-[2-(diamethylamino) ethyl]-n-methyl-1h-indole-5-methanesulphonamide
AU1120599A (en) New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them
NO996108L (no) 9-oksinerytromycinderivater
AU2623095A (en) Piperazine derivatives as 5ht1a antagonists
RU94045149A (ru) Средство ингибирования легочных гипертонических заболеваний
NO982222L (no) 3-(4-Subst.-piperidinyl-1)-1-(3,4-diklorfenyl)propylkarbamater og -ureaer og derivater som neurokinin-antagonister
NO943875D0 (no) Hemming av angiogenese og angiogene sykdommer
AU8154194A (en) Method for increasing libido in post-menopausal women
GB9601722D0 (en) Heterocyclic derivatives
PH25106A (en) 1-acyl-3-(4-(2-pyrimidinyl)-1-piperazinyl) propanes, pharmaceutical composition containing said compound and method of use thereof
AU563738B2 (en) Furan derivatives
NO965050L (no) A- og B-polymorfene av 1-(difenylmetyl)-4- 3-(2-fenyl-1,3-dioksolan-2-yl)propyl -piperazin
NO308002B1 (no) N-p-halogenbenzoylmetylderivater av 4-(p-fluorfenyl)-3-[[3,4- metylendioksy)fenoksy]metyl]piperidin, farmasøytisk preparat inneholdende slike derivater, og anvendelse derav
RU95102147A (ru) Производные 1-[2-(1н-инден-3-ил)этил]-4-(нафт-1-ил)пиперазина, способ их получения и содержащие их медикамент и фармацевтический состав
NO970783L (no) Fremgangsmåte for å hindre endometrialkreft
AU4373785A (en) Dibenzyl-imidazole derivatives
RU95105338A (ru) Трициклические цефемсульфоны, способ их получения, композиция
NO970784L (no) Fremgangsmåte for opprettholdelse av tenner og oralt ben
CA2359958A1 (en) Process for preparing 1-(6-methylpyridin-3yl)-2-[(4-methylsulfonyl)phenyl]ethanone
MX9702532A (es) Composiciones farmaceuticas para el tratamiento de la rinitis.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application